Literature DB >> 25439402

Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias.

Alparslan Turan1, C Allen Bashour2, Jing You3, Yordanka Kirkova4, Andrea Kurz5, Daniel I Sessler5, Leif Saager5.   

Abstract

STUDY
OBJECTIVE: To determine whether postoperative cardiac surgery patients who are sedated with dexmedetomidine have fewer atrial arrhythmias, and whether dexmedetomidine is associated with fewer renal and more gastrointestinal (GI) complications.
DESIGN: Retrospective study.
SETTING: Urban academic hospital. MEASUREMENTS: The records of 765 postoperative cardiac surgery patients who were given dexmedetomidine for postoperative sedation in the intensive care unit (ICU) were studied. Data from the hospital's Cardiac Anesthesiology database between the years 2005 and 2010 were evaluated. Records of patients whose ASA physical status was > 4 or who were < 18 years of age were excluded from the study. Patients who were and were not given dexmedetomidine were compared for postoperative sedation within three days after cardiac surgery using multivariable logistic regression, adjusting for imbalanced covariables. MAIN
RESULTS: The records of 17,776 patients, including 765 cardiac patients given dexmedetomidine for postoperative sedation in the ICU, were reviewed. Patients who received postoperative dexmedetomidine had a lower risk of having atrial arrhythmias: (OR 0.74 (95% CI: 0.60, 0.91; P = 0.004). Dexmedetomidine was not associated with 30-day mortality (1.10, 0.40 - 3.02; P = 0.86), or with any of the following 30-day outcomes: surgical infection (0.72, 0.36-1.42; P = 0.34), systemic infection (1.38, 0.93 - 2.05; P = 0.11), GI complications (1.34, 0.74 - 2.42; P = 0.33), or renal complications (1.23, 0.70 - 2.15; P = 0.48).
CONCLUSIONS: Dexmedetomidine use after cardiac surgery was associated with a lower incidence of atrial arrhythmias.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anesthesia; Atrial arrhythmia; Cardiac surgery; Dexmedetomidine; Sedation

Mesh:

Substances:

Year:  2014        PMID: 25439402     DOI: 10.1016/j.jclinane.2014.05.009

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  6 in total

1.  Dexmedetomidine protects against acute kidney injury through downregulating inflammatory reactions in endotoxemia rats.

Authors:  Fang Tan; Yujie Chen; Dongdong Yuan; Culian Gong; Xiaoyun Li; Shaoli Zhou
Journal:  Biomed Rep       Date:  2015-02-12

2.  Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial.

Authors:  Xu Liu; Kai Zhang; Wei Wang; Guohao Xie; Xiangming Fang
Journal:  Crit Care       Date:  2016-09-21       Impact factor: 9.097

Review 3.  Dexmedetomidine as a promising prevention strategy for cardiac surgery-associated acute kidney injury: a meta-analysis.

Authors:  Rui Shi; Hong-Tao Tie
Journal:  Crit Care       Date:  2017-08-03       Impact factor: 9.097

4.  Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: A meta-analysis and systematic review.

Authors:  Zheng Gong; Li Ma; Yu-Lin Zhong; Jun Li; Jing Lv; Yu-Bo Xie
Journal:  Exp Ther Med       Date:  2017-03-13       Impact factor: 2.447

Review 5.  Can dexmedetomidine reduce atrial fibrillation after cardiac surgery? A systematic review and meta-analysis.

Authors:  Zhipeng Zhu; Hongmei Zhou; Yunjian Ni; Cheng Wu; Caijun Zhang; Xiaoyan Ling
Journal:  Drug Des Devel Ther       Date:  2018-03-12       Impact factor: 4.162

6.  Use of a meta-analysis to assess the preventive effect of dexmedetomidine on cardiac surgery-associated acute kidney injury.

Authors:  Gui-Zhen Yang; Fu-Shan Xue; Ya-Yang Liu
Journal:  Crit Care       Date:  2018-03-27       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.